African Ancestry Linked to Triple-Negative Breast Cancer
The FDA has approved glycopyrrolate oral solution for the treatment of patients aged 3 to 16 years with chronic severe drooling associated with neurologic conditions, such as cerebral palsy.
Medscape Medical News
Sanofi-Aventis Sues FDA Over Generic Lovenox Approval
The Lovenox manufacturer wants the FDA to reverse the approval decision it made last week, on grounds that the generic product is not clinically equivalent to its own product.
Heartwire
First-line Latanoprost Therapy in Ocular Hypertension or Open-angle Glaucoma Patients: a 3-month Efficacy Analysis Stratified by Initial Intraocular Pressure
How effective is latanoprost in the treatment of both glaucoma and ocular hypertension?
BMC Ophthalmology